Open AccessOR03-1 Achievement of HbA1c <6.5% without weight gain and hypoglycemia in people with type 2 diabetes treated with tirzepatide across the phase 3 SURPASS program
Author(s) -
Sheryl Allen,
Alice Cheng,
Pratik Choudhary,
Joshua A. Levine,
Kari Ranta,
Vivian T. Thieu,
Elisa Gomez Valderas,
Ildiko Lingvay
Publication year - 2022
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/jendso/bvac150.722
Subject(s) - hypoglycemia , medicine , placebo , discontinuation , weight gain , clinical endpoint , type 2 diabetes , weight loss , diabetes mellitus , gastroenterology , endocrinology , clinical trial , body weight , obesity , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom